In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Eliot A. Brinton, MD, FAHA, FNLA, FACE
President
Utah Lipid Center
Salt Lake City, UT
Consulting Fees: Amarin, Esperion, Kowa
Commercial Interest Speakers Bureau: Amarin, Amgen, Boehringer, Kowa, Merck, Nova, Regeneron, Sanofi
Stephen M. Cohen, MD, FACOG
Faculty
SUNY Upstate Medical School
Syracuse, NY
Consulting Fees: AbbVie
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Associate Professor of Medicine and Epidemiology
Director of Women's Cardiovascular Health
Associate Director of Preventive Cardiology
Associate Faculty of the Welch Center for Prevention, Epidemiology, and Clinical Research
Division of Cardiology
Johns Hopkins University School of Medicine
Baltimore, MD
No relationships reported
Anita L. Nelson, MD
Professor
Department of Obstetrics and Gynecology
Harbor-UCLA Medical Center
Torrance, CA
Consulting Fees: Agile Therapeutics, AMAG, American Regent, Bayer HealthCare, Merck, Sebela Pharmaceutical, TherapeuticsMD
Commercial Interest Speakers Bureau: American Regent, Bayer HealthCare, Merck, TherapeuticsMD
Contracted Research: Agile Therapeutics, EvoFem, Merck, Mithra, Sebela Pharmaceutical
John R. Nelson, MD, FACC, FNLA, FASNC
Director, California Cardiovascular Institute
CA-ACC-Governmental Relations Committee Member
Fresno, CA
Consulting Fees: Amarin
Speakers Bureau: Amarin, Amgen, Boehringer Ingelheim, Lilly
Stocks: Amarin, Amgen, Pfizer
David J. Portman, MD
Founder and Director, Columbus Center for Women’s Health Research
Adjunct Faculty, The Ohio State University
Department of Obstetrics and Gynecology
Founder and CEO, Sermonix Pharmaceuticals
Columbus, OH
Grant/Research Support: Shionogi Pharmaceuticals, QuatRx Pharmaceuticals, Boehringer Ingelheim, Palatin Technologies, Endoceutics, TherapeuticsMD
Consultant/Advisory Board: Duchesnay Pharmaceuticals, AMAG Pharmaceuticals, Agile Therapeutics, ITF Pharma
Commercial Interest Speakers Bureau: AMAG Pharmaceuticals
Salary and Stockholder: Sermonix Pharmaceuticals
Jane R. Schwebke, MD
Professor of Medicine/Infectious Diseases
University of Alabama at Birmingham
Birmingham, AL
Consulting Fees: Hologic, Talis
Contracted Research: BD Diagnostics, Hologic, Lupin, Mycovia Pharmaceuticals, SCYNEXIS
Ownership Interest: Talis
Jack David Sobel, MD
Dean of the School of Medicine
Professor of Internal Medicine (Infectious Disease) and Obstetrics and Gynecology
Wayne State University,
Detroit, MI
Consulting Fees: Mycovia Pharmaceuticals, SCYNEXIS
Royalty: Up-To-Date
James A. Underberg, MD, MS, FACP, FNLA
Clinical Lipidology
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease
Director, Bellevue Hospital Lipid Clinic
New York, NY
Consulting Fees: Ambry, Amgen
Speakers Bureau: Alexion, Amarin, Amgen, Sanofi
Contracted Research: Aegerion, Pfizer
Advisory Board: Alexion, Amarin, Ambry, Amgen, Esperion, Medicines Company, Regeneron, Sanofi
Sateria Venable
Founder & CEO of The Fibroid Foundation
Bethesda, MD
No relationships reported
Thomas C. Wright, Jr., MD
Professor Emeritus of Pathology and Cell Biology
Columbia University
New York, NY
Pathologist
Enzo Clinical Laboratories
Farmingdale, NY
Consulting Fees: BD, Inovio, Roche Diagnostics
Reviewers/Planners/Authors:
Name of Reviewer/Planner/Author | Reported Areas of Conflict |
Cathy Aubel | No relationships reported |
Sean T. Barrett | No relationships reported |
Eliot Brinton, MD, FAHA, FNLA | Consulting Fees: Amarin, Esperion, Kowa Commercial Interest Speakers Bureau: Amarin, Amgen, Boehringer, Kowa, Merck, Nova, Regeneron, Sanofi |
Ben Caref, PhD | No relationships reported |
Stephen Chavez | No relationships reported |
Stephen M. Cohen, MD, FACOG | Consulting Fees: AbbVie |
Barry A. Fiedel, PhD | No relationships reported |
Sue Grossman | No relationships reported |
Amanda Hilferty | No relationships reported |
Elizabeth Lurwick | No relationships reported |
William Mencia, MD, FACEHP, CHCP | No relationships reported |
Erin D. Michos, MD | No relationships reported |
Anita L. Nelson, MD | Grants/Research: Agile Therapeutics, Evofem, Merck, Sebela Pharmaceutical Honoraria/Speakers Bureau: American Regent, Bayer HealthCare, Merck, TherapeuticsMD Consultant/Advisory Board: Agile Therapeutics, AMAG, American Regent, Bayer HealthCare, Merck, TherapeuticsMD |
David J. Portman, MD | Advisory Board: Evofem Consulting Fees: Agile Therapeutics, Sebela Research Grants: Agile Therapeutics Shareholder: Sermonix Pharmaceuticals |
Jane R. Schwebke, MD | Consulting Fees: Hologic, Talis Contracted Research: BD Diagnostics, Hologic, Lupin, Mycovia Pharmaceuticals, SCYNEXIS Ownership Interest: Talis |
Robert Schneider, MSW | No relationships reported |
Jack D. Sobel, MD | Consulting Fees: Mycovia Pharmaceuticals, SCYNEXIS Royalty: Up-To-Date |
Sateria Venable | No relationships reported |
Thomas C. Wright, Jr, MD | Consulting Fees: BD, Inovio, Roche Diagnostics |
Facebook Comments